OBJECTIVE: To determine the contribution of rare variants as genetic modifiers of the expressivity, penetrance, and severity of systemic sclerosis (SSc). METHODS: We performed whole-exome sequencing of 78 European American patients with SSc, including 35 patients without pulmonary arterial hypertension (PAH) and 43 patients with PAH. Association testing of case-control probability for rare variants was performed using the unified sequence kernel association test with optimal kernel weighting and small sample adjustment by comparing all SSc patients with a reference population of 3,179 controls from the Exome Sequencing Project 5,500 exome data set. Replication genotyping was performed in an independent sample of 3,263 patients (415 patients with SSc and 2,848 controls). We conducted expression profiling of messenger RNA from 61 SSc patients (19 without PAH and 42 with PAH) and 41 corresponding controls. RESULTS: The ATP8B4 gene was associated with a significant increase in the risk of SSc (P = 2.77 × 10(-7)). Among the 64 ATP8B4 variants tested, a single missense variant, c.1308C>G (F436L, rs55687265), provided the most compelling evidence of association (P = 9.35 × 10(-10), odds ratio [OR] 6.11), which was confirmed in the replication cohort (P = 0.012, OR 1.86) and meta-analysis (P = 1.92 × 10(-7), OR 2.5). Genes involved in E3 ubiquitin-protein ligase complex (ASB10) and cyclic nucleotide gated channelopathies (CNGB3) as well as HLA-DRB5 and HSPB2 (heat-shock protein 27) provided additional evidence of association (P < 10(-5)). Differential ATP8B4 expression was observed among the SSc patients compared to the controls (P = 0.0005). CONCLUSION: ATP8B4 may represent a putative genetic risk factor for SSc and pulmonary vascular complications.
OBJECTIVE: To determine the contribution of rare variants as genetic modifiers of the expressivity, penetrance, and severity of systemic sclerosis (SSc). METHODS: We performed whole-exome sequencing of 78 European American patients with SSc, including 35 patients without pulmonary arterial hypertension (PAH) and 43 patients with PAH. Association testing of case-control probability for rare variants was performed using the unified sequence kernel association test with optimal kernel weighting and small sample adjustment by comparing all SSc patients with a reference population of 3,179 controls from the Exome Sequencing Project 5,500 exome data set. Replication genotyping was performed in an independent sample of 3,263 patients (415 patients with SSc and 2,848 controls). We conducted expression profiling of messenger RNA from 61 SSc patients (19 without PAH and 42 with PAH) and 41 corresponding controls. RESULTS: The ATP8B4 gene was associated with a significant increase in the risk of SSc (P = 2.77 × 10(-7)). Among the 64 ATP8B4 variants tested, a single missense variant, c.1308C>G (F436L, rs55687265), provided the most compelling evidence of association (P = 9.35 × 10(-10), odds ratio [OR] 6.11), which was confirmed in the replication cohort (P = 0.012, OR 1.86) and meta-analysis (P = 1.92 × 10(-7), OR 2.5). Genes involved in E3 ubiquitin-protein ligase complex (ASB10) and cyclic nucleotide gated channelopathies (CNGB3) as well as HLA-DRB5 and HSPB2 (heat-shock protein 27) provided additional evidence of association (P < 10(-5)). Differential ATP8B4 expression was observed among the SSc patients compared to the controls (P = 0.0005). CONCLUSION:ATP8B4 may represent a putative genetic risk factor for SSc and pulmonary vascular complications.
Authors: Lara Bossini-Castillo; Jose-Ezequiel Martin; Jasper Broen; Olga Gorlova; Carmen P Simeón; Lorenzo Beretta; Madelon C Vonk; Jose Luis Callejas; Ivan Castellví; Patricia Carreira; Francisco José García-Hernández; Mónica Fernández Castro; Marieke J H Coenen; Gabriela Riemekasten; Torsten Witte; Nicolas Hunzelmann; Alexander Kreuter; Jörg H W Distler; Bobby P Koeleman; Alexandre E Voskuyl; Annemie J Schuerwegh; Øyvind Palm; Roger Hesselstrand; Annika Nordin; Paolo Airó; Claudio Lunardi; Raffaella Scorza; Paul Shiels; Jacob M van Laar; Ariane Herrick; Jane Worthington; Christopher Denton; Filemon K Tan; Frank C Arnett; Sandeep K Agarwal; Shervin Assassi; Carmen Fonseca; Maureen D Mayes; Timothy R D J Radstake; Javier Martin Journal: Hum Mol Genet Date: 2011-11-10 Impact factor: 6.150
Authors: Harjot K Saini-Chohan; Shyamala Dakshinamurti; William A Taylor; Garry X Shen; Robert Murphy; Genevieve C Sparagna; Grant M Hatch Journal: Am J Physiol Heart Circ Physiol Date: 2011-08-12 Impact factor: 4.733
Authors: Yannick Allanore; Mohamad Saad; Philippe Dieudé; Jérôme Avouac; Jorg H W Distler; Philippe Amouyel; Marco Matucci-Cerinic; Gabriella Riemekasten; Paolo Airo; Inga Melchers; Eric Hachulla; Daniele Cusi; H-Erich Wichmann; Julien Wipff; Jean-Charles Lambert; Nicolas Hunzelmann; Kiet Tiev; Paola Caramaschi; Elisabeth Diot; Otylia Kowal-Bielecka; Gabriele Valentini; Luc Mouthon; László Czirják; Nemanja Damjanov; Erika Salvi; Costanza Conti; Martina Müller; Ulf Müller-Ladner; Valeria Riccieri; Barbara Ruiz; Jean-Luc Cracowski; Luc Letenneur; Anne Marie Dupuy; Oliver Meyer; André Kahan; Arnold Munnich; Catherine Boileau; Maria Martinez Journal: PLoS Genet Date: 2011-07-07 Impact factor: 5.917
Authors: David C Gadsby; Francisco Bezanilla; Robert F Rakowski; Paul De Weer; Miguel Holmgren Journal: Nat Commun Date: 2012-02-14 Impact factor: 14.919
Authors: Sekar Kathiresan; Alisa K Manning; Serkalem Demissie; Ralph B D'Agostino; Aarti Surti; Candace Guiducci; Lauren Gianniny; Nöel P Burtt; Olle Melander; Marju Orho-Melander; Donna K Arnett; Gina M Peloso; Jose M Ordovas; L Adrienne Cupples Journal: BMC Med Genet Date: 2007-09-19 Impact factor: 2.103
Authors: Hao Li; Sally Wetten; Li Li; Pamela L St Jean; Ruchi Upmanyu; Linda Surh; David Hosford; Michael R Barnes; James David Briley; Michael Borrie; Natalie Coletta; Richard Delisle; Daniella Dhalla; Margaret G Ehm; Howard H Feldman; Luis Fornazzari; Serge Gauthier; Neil Goodgame; Danilo Guzman; Sandra Hammond; Paul Hollingworth; Ging-Yuek Hsiung; Joan Johnson; Devon D Kelly; Ron Keren; Andrew Kertesz; Karen S King; Simon Lovestone; Inge Loy-English; Paul M Matthews; Michael J Owen; Mary Plumpton; William Pryse-Phillips; Rab K Prinjha; Jill C Richardson; Ann Saunders; Andrew J Slater; Peter H St George-Hyslop; Sandra W Stinnett; Jina E Swartz; Rachel L Taylor; John Wherrett; Julie Williams; David P Yarnall; Rachel A Gibson; Michael C Irizarry; Lefkos T Middleton; Allen D Roses Journal: Arch Neurol Date: 2007-11-12
Authors: Angel C Y Mak; Paul L F Tang; Clare Cleveland; Melanie H Smith; M Kari Connolly; Tamiko R Katsumoto; Paul J Wolters; Pui-Yan Kwok; Lindsey A Criswell Journal: Arthritis Rheumatol Date: 2016-09 Impact factor: 10.995
Authors: Pravitt Gourh; Elaine F Remmers; Steven E Boyden; Theresa Alexander; Nadia D Morgan; Ami A Shah; Maureen D Mayes; Ayo Doumatey; Amy R Bentley; Daniel Shriner; Robyn T Domsic; Thomas A Medsger; Virginia D Steen; Paula S Ramos; Richard M Silver; Benjamin Korman; John Varga; Elena Schiopu; Dinesh Khanna; Vivien Hsu; Jessica K Gordon; Lesley Ann Saketkoo; Heather Gladue; Brynn Kron; Lindsey A Criswell; Chris T Derk; S Louis Bridges; Victoria K Shanmugam; Kathleen D Kolstad; Lorinda Chung; Reem Jan; Elana J Bernstein; Avram Goldberg; Marcin Trojanowski; Suzanne Kafaja; Kathleen M Maksimowicz-McKinnon; James C Mullikin; Adebowale Adeyemo; Charles Rotimi; Francesco Boin; Daniel L Kastner; Fredrick M Wigley Journal: Arthritis Rheumatol Date: 2018-08-29 Impact factor: 10.995
Authors: Christopher J Cardinale; Dong Li; Lifeng Tian; John J Connolly; Michael E March; Cuiping Hou; Fengxiang Wang; James Snyder; Cecilia E Kim; Rosetta M Chiavacci; Patrick M Sleiman; Jon M Burnham; Hakon Hakonarson Journal: BMC Musculoskelet Disord Date: 2016-11-09 Impact factor: 2.362
Authors: Hilary Coon; Todd M Darlington; Emily DiBlasi; W Brandon Callor; Elliott Ferris; Alison Fraser; Zhe Yu; Nancy William; Sujan C Das; Sheila E Crowell; Danli Chen; John S Anderson; Michael Klein; Leslie Jerominski; Dale Cannon; Andrey Shabalin; Anna Docherty; Megan Williams; Ken R Smith; Brooks Keeshin; Amanda V Bakian; Erik Christensen; Qingqin S Li; Nicola J Camp; Douglas Gray Journal: Mol Psychiatry Date: 2018-10-23 Impact factor: 15.992